John F. Milligan

CIK: 0001191589

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

FDMT

4D Molecular Therapeutics, Inc.

Director

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Director

KLRA

Kailera Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

FDMT
4D Molecular Therapeutics, Inc.
Jun 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
75K shares-
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Jun 3, 2026
Award(A)
Stock Option (right to buy)
Direct
223.5K shares-
KLRA
Kailera Therapeutics, Inc.
Apr 16, 2026
Award(A)
Stock Option (right to buy)
Direct
38.3K shares-
FDMT
4D Molecular Therapeutics, Inc.
Jun 17, 2025
Award(A)
Stock Option (Right to Buy)
Direct
33.8K shares-
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Jun 4, 2025
Award(A)
Stock Option (right to buy)
Direct
65K shares-

		Type	Shares	Price		Ownership
Jun 17, 2026	FDMT 4D Molecular Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	75,000	-	-	Direct
Jun 3, 2026	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Award(A) Stock Option (right to buy)	223,492	-	-	Direct
Apr 16, 2026	KLRA Kailera Therapeutics, Inc.	Award(A) Stock Option (right to buy)	38,300	-	-	Direct
Jun 17, 2025	FDMT 4D Molecular Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	33,750	-	-	Direct
Jun 4, 2025	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Award(A) Stock Option (right to buy)	65,000	-	-	Direct

1-5 of 5 transactions

About MILLIGAN JOHN F

MILLIGAN JOHN F (SEC CIK 0001191589) files insider reports with the SEC as Director of 4D Molecular Therapeutics, Inc. (FDMT), Director of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and Director of Kailera Therapeutics, Inc. (KLRA).

Signal8 holds 6 ownership filings by MILLIGAN JOHN F (1 Form 3, 5 Form 4), filed between Jun 6, 2025 and Jun 18, 2026. Those filings report 5 transactions, from Jun 4, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MILLIGAN JOHN F's filings is in MENLO PARK, CA.

Recent filings by MILLIGAN JOHN F

Jun 17, 2026: Grant or award of FDMT derivative securities (Form 4, code A).
Jun 3, 2026: Grant or award of PACB derivative securities (Form 4, code A).
Apr 16, 2026: Grant or award of KLRA derivative securities (Form 4, code A).
Jun 17, 2025: Grant or award of FDMT derivative securities (Form 4, code A).
Jun 4, 2025: Grant or award of PACB derivative securities (Form 4, code A).

Other insiders filing for 4D Molecular Therapeutics, Inc. (FDMT)

Bizily Scott, Chief Legal Officer
Kirn David
Tomasello Shawn, Director
THEUER CHARLES, Director
Miller-Rich Nancy, Director
GRAY SUSANNAH, Director

How to read Form 4 transaction codes